Page last updated: 2024-08-17

cordycepin and Angiogenesis, Pathologic

cordycepin has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, M; Jin, G; Lin, Z; Liu, T; Lv, Y; Ren, X; Wang, X; Yan, W; Zhu, G	1

Other Studies

1 other study(ies) available for cordycepin and Angiogenesis, Pathologic

Article	Year
Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma. The Journal of pharmacology and experimental therapeutics, 2020, Volume: 373, Issue:2 Topics: Animals; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Chromosomal Proteins, Non-Histone; Deoxyadenosines; Extracellular Signal-Regulated MAP Kinases; Humans; Male; MAP Kinase Signaling System; Mice; Neovascularization, Pathologic; Oncogene Proteins; Poly-ADP-Ribose Binding Proteins; Xenograft Model Antitumor Assays	2020

Article

Year

Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.

The Journal of pharmacology and experimental therapeutics, 2020, Volume: 373, Issue:2

Topics: Animals; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Chromosomal Proteins, Non-Histone; Deoxyadenosines; Extracellular Signal-Regulated MAP Kinases; Humans; Male; MAP Kinase Signaling System; Mice; Neovascularization, Pathologic; Oncogene Proteins; Poly-ADP-Ribose Binding Proteins; Xenograft Model Antitumor Assays

2020